Citazione APA

Tsuboi, K., & Yamamoto, H. (2017). Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients. BMC Pharmacol Toxicol.

Stile di citazione Chicago

Tsuboi, Kazuya, e Hiroshi Yamamoto. "Efficacy and Safety of Enzyme-replacement-therapy With Agalsidase Alfa in 36 Treatment-naïve Fabry Disease Patients." BMC Pharmacol Toxicol 2017.

Citazione MLA

Tsuboi, Kazuya, e Hiroshi Yamamoto. "Efficacy and Safety of Enzyme-replacement-therapy With Agalsidase Alfa in 36 Treatment-naïve Fabry Disease Patients." BMC Pharmacol Toxicol 2017.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.